IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, W. O.
Right arrow Articles by Hoffman, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, W. O.
Right arrow Articles by Hoffman, S. L.
Infection and Immunity, August 2002, p. 4329-4335, Vol. 70, No. 8
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.8.4329-4335.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Protection of Rhesus Macaques against Lethal Plasmodium knowlesi Malaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization Regimen

William O. Rogers,1* Walter R. Weiss,1 Anita Kumar,1 João C. Aguiar,1 John A. Tine,2,{dagger} Robert Gwadz,3 Joseph G. Harre,4,{ddagger} Kalpana Gowda,1 Dharmendar Rathore,3 Sanjai Kumar,1 and Stephen L. Hoffman1,§

Malaria Program, Naval Medical Research Center, Silver Spring, Maryland 20910,1 Virogenetics Corporation, Rensselaer Technology Park, Troy, New York 12180,2 Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20889,3 Division of Veterinary Medicine, Walter Reed Army Institute of Research, Silver Spring, Maryland 209104

Received 4 December 2001/ Returned for modification 2 February 2002/ Accepted 19 April 2002

We tested a cytokine-enhanced, multiantigen, DNA priming and poxvirus boosting vaccine regimen for prevention of malaria in the Plasmodium knowlesi-rhesus macaque model system. Animals were primed with a mixture of DNA plasmids encoding two preerythrocytic-stage proteins and two erythrocytic-stage proteins from P. knowlesi and combinations of the cytokines granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor alpha and were boosted with a mixture of four recombinant, attenuated vaccinia virus strains encoding the four P. knowlesi antigens. Two weeks after boosting, the geometric mean immunofluorescence titers in the immunized groups against sporozoites and infected erythrocytes ranged from 160 to 8,096 and from 1,810 to 5,120, respectively. The geometric mean anti-P. knowlesi circumsporozoite protein (PkCSP) titers ranged from 1,761 to 24,242. Peripheral blood mononuclear cells (PBMC) from the immunized monkeys produced gamma interferon (IFN-{gamma}) in response to incubation with pooled peptides from the PkCSP at frequencies of 10 to 571 spot-forming cells/106 PBMC. Following challenge with 100 infectious P. knowlesi sporozoites, 2 of 11 immunized monkeys were sterilely protected, and 7 of the 9 infected monkeys resolved their parasitemias spontaneously. In contrast, all four controls became infected and required treatment for overwhelming parasitemia. Early protection was strongly associated with IFN-{gamma} responses against a pool of peptides from the preerythrocytic-stage antigen, PkCSP. These findings demonstrate that a multistage, multiantigen, DNA priming and poxvirus boosting vaccine regimen can protect nonhuman primates from an otherwise lethal malaria sporozoite challenge.


* Corresponding author. Present address: Naval Medical Research Unit 3, Ghana, c/o Department of State, 2020 Accra Place, Washington, DC 20521-2020. Phone: 233 21 513207. Fax: 233 21 502182. E-mail: brogers{at}noguchi.mimcom.net.

Editor: W. A. Petri, Jr.

{dagger} Present address: Center for Comparative Functional Genomics, University at Albany, SUNY, Rensselaer, NY 12144.

{ddagger} Present address: 81 MDSS/SGSFE, Keesler AFB, MS 39534-2519.

§ Present address: Celera Genomics, Rockville, MD 20850.


Infection and Immunity, August 2002, p. 4329-4335, Vol. 70, No. 8
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.8.4329-4335.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2002 by the American Society for Microbiology. All rights reserved.